Filtering options
Advanced Analytics
Agreement Studies
Alira Health
Bayesian Design
Biologics
Biometrics
Biopharma
Biostatistics
Biotech
Bordeaux
Business Strategy
Capital Injection
CDMO
Clinical
Clinical Operations
Clinical Trial Management
Clinical Trials
CMC
Contract Development and Manufacturing
CRO
Crowdfunding
Data Science
Data Specialist
Decentralized Clinical Trials
Dermatology
Diabetes
Diagnotics
Digital Health
Digital Therapeutics
Digital Transformation
Diversity
DPHARM
Drug Development
DTx
DTx trends
Due Diligence
eCOA
Economic Policy
Environmental Policy
EU
European Medicines Agency
France
Funding
Genomic Testing
Health Economics
Health Policy
Healthcare Consulting
Healthcare Technology
HEOR
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Inclusion
Innovation
Investor Relations
IVDR
Leadership
Life Sciences
M&A
Market Access
Medical Devices
Medical Robotics
MedTech
Mobile Tech
Oncology
Orphan Drug
Outcomes Research
Outsourcing Clinical Trials
Patient Advocacy
Patient Centric
Patient Centricity
Patient Engagement
Pharma
Product Development
Rare Disease
Rare Disease Trials
Real-World Evidence
Registry-based studies
Regulatory
Research & Development
Research and Development
Robotcs
RWE
Spain
Startups
Teamwork
Therapeutics
Vaccines
Wound Healing
All
Events
Latest from Alira Health
The Next Iteration Podcast: Gabriele Brambilla on Leadership, and Work Culture in Europe and the West
Gabriele Brambilla, CEO and Co-Founder of Alira Health, joined The Next Iteration Podcast with hosts Damien Joseph and Fuad Ali to share his experiences of founding and developing Alira(...)
Webinar Replay: Partnering with Patients to Streamline Trial Operations: Protocol to Regulatory Submission in 60 days
Learn how patients and patient advocacy organizations can be directly enabled as powerful partners to facilitate all stages of DCT deployment, from protocol design, recruitment, engagement(...)
Webinar Replay: Health Economics and Outcomes Research (HEOR) for Medical Technologies for the US Healthcare System
A well-designed Health Economics and Outcomes Research (HEOR) study is vital for generating short- and long-term effectiveness data. Attend the webinar to gain a stepwise strategic(...)
Myasthenia Gravis Foundation of America (MGFA) Re-launches the MGFA Global MG Patient Registry with Partner Alira Health
The registry enables patients diagnosed with MG to securely, safely submit their health and symptom data that will help researchers design and drive new research studies and clinical(...)
TerSera Therapeutics to sponsor “NET Cancer Health Storylines” by Alira Health and Carcinoid Cancer Foundation to support patients suffering from Carcinoid Syndrome Diarrhea
We are pleased to announce TerSera Therapeutics’ sponsorship with the Carcinoid Cancer Foundation (CCF) and Alira Health to expand and optimize a holistic patient journey digital(...)
Alira Health Appoints Annabel de Maria Chief Patient Officer, Leading Global Patient Partnerships
Alira Health is pleased to announce today the appointment of Annabel de Maria as Chief Patient Officer. In this leadership capacity, she will spearhead the central role of patient engagement(...)
Alligator-Derived Hyaluronic Acid: Bacteriostatic and Fungastatic Properties Against Pathogens
Considering that alligator tissues have been found to have bacteriostatic and fungistatic properties, it is possible that alligator-derived hyaluronic acid may play a critical role(...)
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Medical Device Regulation in 2023: A Window of Opportunity
We spoke with our team of regulatory experts about the recent news regarding the MDR and the opportunity it presents to device manufacturers in 2023.
Subscribe to our newsletter for the latest news, events, and thought leadership